Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

IVF Time-lapse Imaging Devices Market Size & Growth Forecast 2026–2035, By Segments (End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13533| Published Date: May-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

IVF Time-lapse Imaging Devices Market size was more than USD 590.22 Million in 2025 and is set to grow at a 23% CAGR between 2026 and 2035, reaching USD 4.68 Billion by 2035. The industry revenue for 2026 is calculated at USD 713.52 million.

Base Year Value (2025)
USD 590.22 Million
CAGR (2026-2035)
23%
Forecast Year Value (2035)
USD 4.68 Billion
Historical Data Period
2022-2025
Largest Region
Europe
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

IVF Time-lapse Imaging Devices Market Intelligence Snapshot

Regional Market Dynamics

  • Europe accounted for 38.27% of the market in 2025, supported by established fertility care infrastructure, widespread use of embryo monitoring technologies, and routine integration into IVF laboratory workflows.
  • Asia Pacific is expected to expand at a 25.3% CAGR as fertility clinics upgrade laboratory capabilities, adopt advanced embryo monitoring systems, and expand treatment capacity across growing clinic networks.

Segment Momentum

  • Hospitals & Other Settings accounted for 73.92% of the market in 2025, supported by established embryology workflows, centralized laboratory resources, and broader procedural capacity for assisted reproductive services.
  • Fertility Clinics are the fastest-growing segment because their specialized embryo monitoring and IVF treatment workflows enable quicker adoption of time-lapse imaging technologies that support core fertility services.

Market Expansion Drivers

  • Rising infertility rates driven by lifestyle stress and delayed parenthood trends globally.
  • AI-enabled embryo selection improving IVF success rates and clinical decision accuracy.
  • Growing fertility preservation and delayed parenthood trends expanding IVF treatment demand.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Major companies in the IVF time-lapse imaging devices market include Vitrolife AB (Sweden), Esco Medical Technologies UAB (Lithuania), Genea Biomedx Pty Ltd. (Australia), ASTEC Co., Ltd. (Japan), Merck KGaA (Germany), FUJIFILM Irvine Scientific, Inc. (United States), CooperSurgical, Inc. (United States), Hamilton Thorne Ltd. (Canada).

Regional and Segment Outlook

Europe
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising infertility rates driven by lifestyle stress and delayed parenthood trends globally

As infertility becomes more closely associated with later maternal age, stress-related reproductive health issues, and other lifestyle-linked factors, fertility clinics are seeing a broader and more medically complex patient base. That shift is driving demand for the IVF time-lapse imaging devices market because clinics need tools that support closer embryo monitoring without repeated disturbance during incubation, especially when treatment cycles are costly, emotionally sensitive, and often limited in number. In practice, higher case volumes and greater pressure to optimize embryo selection are influencing purchasing decisions toward integrated imaging systems that help embryologists manage more patients while preserving consistent observation quality.

AI-enabled embryo selection improving IVF success rates and clinical decision accuracy

AI-assisted embryo assessment is driving market development by turning time-lapse imaging from a monitoring tool into a decision-support platform for embryo selection. In the IVF time-lapse imaging devices market, this changes buyer behavior at the clinic level: providers are more willing to invest in imaging systems when they can pair continuous embryo development data with algorithm-based scoring that reduces subjectivity in embryologist interpretation. The practical effect is a clearer clinical and economic rationale for adoption, as centers seek to improve selection consistency, support treatment outcomes, and differentiate their IVF services through more data-driven decision-making.

Growing fertility preservation and delayed parenthood trends expanding IVF treatment demand

The expansion of egg freezing and other fertility preservation pathways is increasing market penetration by bringing more patients into assisted reproduction earlier, even before immediate conception attempts begin. For the IVF time-lapse imaging devices market, this matters because delayed parenthood often translates into later IVF utilization, while preservation programs deepen clinic infrastructure needs over time and normalize advanced reproductive technologies among a wider patient population. As fertility centers build services around long-term reproductive planning rather than only infertility treatment, demand for sophisticated embryo culture and observation systems becomes more embedded in routine clinical investment.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising infertility rates driven by lifestyle stress and delayed parenthood trends globally 2.30% High Global High Near Term
AI-enabled embryo selection improving IVF success rates and clinical decision accuracy 2.00% Moderate North America, Europe Medium Mid Term
Growing fertility preservation and delayed parenthood trends expanding IVF treatment demand 1.80% Moderate Asia Pacific, North America, Europe Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
Europe
38.27% Market Share in 2025
Europe (Largest Region) vs Asia Pacific (Fastest-Growing Region)

Europe held a 38.27% share of the IVF time-lapse imaging devices market in 2025, bolstered by the region’s established assisted reproductive technology infrastructure, broad concentration of fertility clinics, and routine integration of advanced embryo monitoring tools into clinical workflows. The region’s leadership is reinforced by consistent use of time-lapse imaging in embryo assessment, where clinics prioritize continuous observation to support selection decisions without repeatedly disturbing culture conditions. That practical fit within established IVF lab operations helps sustain equipment demand across mature fertility care settings.

Asia Pacific is projected to expand at a 25.3% CAGR over the forecast period in the IVF time-lapse imaging devices market, driven by the ongoing buildout of fertility treatment capacity and rising adoption of more technology-enabled embryo monitoring approaches across clinics. Growth is accelerating as providers in the region invest in upgrading IVF laboratory capabilities and incorporate imaging systems that improve workflow efficiency while supporting closer embryo development tracking. As clinic networks widen and treatment volumes increase, demand is being fueled by the need for scalable tools that align with more advanced reproductive care delivery.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Clinical Quality Enhancement

Germany promotes IVF time-lapse imaging devices within fertility centers seeking consistent embryo monitoring and evidence-based treatment approaches. Clinics in Germany prioritize imaging systems that improve laboratory efficiency while supporting informed embryology decisions.

France 🇫🇷

Advanced Embryo Assessment

France continues adopting IVF time-lapse imaging devices to strengthen embryo evaluation within specialized fertility clinics. Healthcare providers in France emphasize technologies that support standardized embryology practices while improving laboratory productivity.

Italy 🇮🇹

Assisted Reproduction Modernization

Italy expands investment in IVF laboratory modernization, encouraging adoption of time-lapse imaging devices for continuous embryo monitoring. Fertility centers in Italy seek systems that improve workflow efficiency and support consistent embryo assessment throughout treatment cycles.

Japan 🇯🇵

Precision Embryology Support

Japan advances the use of IVF time-lapse imaging devices to enhance embryo observation without disrupting incubation conditions. Fertility clinics in Japan increasingly invest in technologies that improve laboratory consistency and optimize assisted reproduction workflows.

South Korea 🇰🇷

Digital Fertility Solutions

South Korea strengthens fertility treatment capabilities through adoption of digitally enabled IVF time-lapse imaging systems. Fertility centers in South Korea focus on advanced embryo monitoring technologies that enhance operational efficiency and clinical decision support.

United States 🇺🇸

Fertility Technology Adoption

The U.S. continues integrating IVF time-lapse imaging devices into fertility clinics to improve embryo assessment and workflow efficiency. Clinics across the U.S. increasingly adopt advanced imaging platforms that support data-driven embryo selection and standardized laboratory practices.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

IVF Time-lapse Imaging Devices Market Share (%), End Use, 2025

Hospitals & Other Settings
Fertility Clinics

Go beyond the chart, access full insights & data tables

Request Free Sample Report
End Use Segment Analysis: Hospitals & Other Settings (Largest Segment) vs Fertility Clinics (Fastest-Growing Segment)

Hospitals & Other Settings held a 73.92% share of the IVF time-lapse imaging devices market in 2025, reflecting their established role in handling a broad range of assisted reproductive procedures within larger clinical infrastructures. This leadership is maintained through the ability of hospital-based environments and affiliated care settings to integrate IVF time-lapse imaging devices into existing embryology workflows, backed by wider procedural capacity, centralized laboratory resources, and multi-specialty clinical support. Their scale and operational continuity make them a practical purchasing base for advanced imaging systems, which helps preserve their leading share in the market.

Fertility Clinics are emerging as the fastest-growing end-use segment in the IVF time-lapse imaging devices market as reproductive care becomes increasingly concentrated in specialized treatment environments. Growth is being backed by the operational fit between dedicated fertility clinics and time-lapse imaging systems, since these providers are typically focused on embryo monitoring, treatment cycle optimization, and patient-specific IVF management. Compared with broader hospital settings, fertility clinics are gaining momentum because their specialized workflows allow faster adoption of technologies that directly support core fertility services.

Segment Sub-Segment Largest Segment Fastest Growing
End Use Fertility Clinics, Hospitals & Other Settings Hospitals & Other Settings Fertility Clinics
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the IVF time-lapse imaging devices market:

1. Vitrolife AB (Sweden)

2. Esco Medical Technologies UAB (Lithuania)

3. Genea Biomedx Pty Ltd. (Australia)

4. ASTEC Co. Ltd. (Japan)

5. Merck KGaA (Germany)

6. FUJIFILM Irvine Scientific Inc. (United States)

7. CooperSurgical Inc. (United States)

8. Hamilton Thorne Ltd. (Canada)

In the IVF time-lapse imaging devices market, advanced imaging technologies are improving embryo monitoring precision and developmental assessment. Continuous product innovation is enhancing visualization capabilities for reproductive procedures. Integrated clinical ecosystems are supporting more informed decision-making in assisted reproduction workflows.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Vitrolife May-24 Vitrolife acquired eFertility, a company specializing in IVF clinic management software systems. The acquisition expands Vitrolife’s presence into digital clinic workflow solutions, integrating reproductive technologies with software-driven operational management tools and strengthening its position across the assisted reproduction ecosystem beyond time-lapse imaging devices.
Gameto May-24 Gameto published research outlining cellular engineering and manufacturing methods behind its Fertilo solution, a vitrification-based in vitro maturation approach using engineered ovarian support cells. The development highlights a biologically engineered workflow designed to enable egg maturation outside the body, supporting both clinical and commercial scaling pathways in assisted reproduction technologies.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

IVF Time-lapse Imaging Devices Market — Custom Segments

Segment Sub-Segment
No segment data available.

IVF Time-lapse Imaging Devices Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How big is the IVF time-lapse imaging devices market?

The market size of IVF time-lapse imaging devices in 2026 is calculated to be USD 713.52 million.

How is the IVF time-lapse imaging devices industry expected to grow over the next 10 years?

IVF Time-lapse Imaging Devices Market size is forecast to climb from USD 590.22 million in 2025 to USD 4.68 billion by 2035 expanding at a CAGR of over 23% during 2026-2035.

How is AI-driven embryo selection influencing adoption of time-lapse imaging systems in IVF clinics?

AI-enabled embryo assessment is increasing adoption by transforming time-lapse imaging into a decision-support tool. Clinics invest in these systems to improve selection consistency, reduce subjectivity, and strengthen treatment outcomes through continuous embryo monitoring data.

How are fertility preservation and delayed parenthood trends expanding demand for IVF time-lapse imaging devices?

Delayed parenthood and rising fertility preservation programs are increasing IVF cycles and long-term clinic engagement. This expands demand for advanced imaging systems that support consistent embryo monitoring and optimize outcomes across increasingly complex patient profiles.

Why do hospitals and other settings dominate the IVF time-lapse imaging devices market?

Hospitals & Other Settings accounted for 73.92% of the market in 2025, supported by established embryology workflows, centralized laboratory resources, and broader procedural capacity for assisted reproductive services.

Which end-use segment is expanding the fastest in the IVF time-lapse imaging devices market?

Fertility Clinics are the fastest-growing segment because their specialized embryo monitoring and IVF treatment workflows enable quicker adoption of time-lapse imaging technologies that support core fertility services.

What factors make Europe the leading market for IVF time-lapse imaging devices?

Europe accounted for 38.27% of the market in 2025, supported by established fertility care infrastructure, widespread use of embryo monitoring technologies, and routine integration into IVF laboratory workflows.

Why is Asia Pacific experiencing the fastest growth in the IVF time-lapse imaging devices market?

Asia Pacific is expected to expand at a 25.3% CAGR as fertility clinics upgrade laboratory capabilities, adopt advanced embryo monitoring systems, and expand treatment capacity across growing clinic networks.

Who are the major participants shaping the IVF time-lapse imaging devices landscape?

Major companies in the IVF time-lapse imaging devices market include Vitrolife AB (Sweden), Esco Medical Technologies UAB (Lithuania), Genea Biomedx Pty Ltd. (Australia), ASTEC Co., Ltd. (Japan), Merck KGaA (Germany), FUJIFILM Irvine Scientific, Inc. (United States), CooperSurgical, Inc. (United States), Hamilton Thorne Ltd. (Canada).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →